Showing results (1001-1010 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|July 3, 2022
Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trialAlberto Domínguez-Rodríguez, Coral Suero-Mendez, Guillermo Burillo-Putze, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
European Journal of Heart Failure|April 1, 2020
Targeting pulmonary capillary permeability to reduce lung congestion in heart failure: a randomized, controlled pilot trialGlenn M Stewart, Bruce D Johnson, Dennis L Sprecher, et al.
European Journal of Heart Failure|April 1, 2020
Mega-trials in heart failure: effects of dilution in examination of new therapiesBeth A Davison, Koji Takagi, Stefanie Senger, et al.
European Journal of Heart Failure|March 27, 2020
The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HFAnkeet S Bhatt, Andrew P Ambrosy, Allison Dunning, et al.
European Journal of Heart Failure|July 16, 2021
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and diseaseAlberto Aimo, Luigi Francesco Saccaro, Chiara Borrelli, et al.
European Journal of Heart Failure|May 29, 2021
Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trialJoão Pedro Ferreira, Marvin A Konstam, John J V McMurray, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
European Journal of Heart Failure|October 9, 2020
Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fractionAlia S Alhakak, Morten Sengeløv, Peter G Jørgensen, et al.
Pageof 398